Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
2025-26 COVID-19 vaccine availability
March 24, 2026
Community pharmacies may provide doses of the 2025-26 COVID-19 vaccine to those at high risk for severe outcomes.
Read more ➞
